Hammond Janet MJ
Atea Pharmaceuticals, Inc. · Chief Development Officer
Hammond Janet MJ is listed in public filings as officer: Chief Development Officer. This Hammond Janet MJ insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Atea Pharmaceuticals, Inc. (AVIR). Investors use Hammond Janet MJ's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $750k177k shares | Grant / ExerciseJan 31, 2026 | $750.5K177k shares | $4.24 | -- | |
| --11.3k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable11.3k shares | -- | -- | |
| --141.8k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable58.1k shares | -- | -- | |
| $541k127.7k shares | Grant / ExerciseJan 31, 2026 | $59.9K14.1k shares | $4.24 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $612k200k shares | Grant / ExerciseJan 31, 2025 | $612.0K200k shares | $3.06 | -- | |
| --11.3k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable11.3k shares | -- | -- | |
| --46.8k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable46.8k shares | -- | -- | |
| $249k81.4k shares | Grant / ExerciseJan 31, 2025 | $43.3K14.1k shares | $3.06 | -- |